Risk-based Monitoring Software Market | Key Factor in Clinical Trial | Market Growth Worth $511 million
Growth in the risk based monitoring software market can primarily be attributed to factors such as
the cost and time efficiency of RBM solutions, rising number of clinical
trials, and increasing government funding and grants to support clinical
trials. However, the high implementation cost of RBM solutions is expected to
restrain the growth of this market during the forecast period.
RBM Software Market Dynamics: Impact Analysis
1. Increased outsourcing of clinical trial processes to CROs
2. Cost and time efficiency of RBM solutions
3. Increasing government funding and grants to support clinical trials
4. Increased pharmaceutical R&D spending
5. Initiatives to boost digital health to propel market growth
The risk-based monitoring (RBM) software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a CAGR of 13.3%
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102112429
Software Component:
The software segment is expected to command the largest share of the RBM software market. The large share of this segment can be attributed to can be attributed to the increasing R&D expenditure in the life science and clinical research industries, an increasing number of clinical trials, and rising customer base.
Web Based (On Demand) Delivery Mode:
The Web-based (On-demand) segment is expected to command the largest share of the RBM software market. The large share of this segment can be attributed to the advantages offered by web-based software, such as easy access, improved productivity, time efficiency, and cost-efficiency.
The pharmaceutical and biopharmaceutical companies segment is expected to command the largest share of the RBM software market.
Key Questions Addressed in The Report:
1. Who are the top 10 players operating in the global RBM Software Market?
2. What are the drivers, restraints, opportunities, and challenges in the RBM Software Industry?
3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of RBM Software Industry in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?
Regional Growth Analysis:
North American market is expected to account for the largest share of the global RBM software market. The Asia Pacific market is expected to grow at the highest CAGR in the forecast period.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=102112429
Key Players:
Oracle (US), Medidata Solutions (US), and Parexel (US). Other prominent players in the market are Bioclinica (US), Bio-Optronics (US), IBM Corporation (US), DATATRAK (US), Veeva Systems (US), DSG (US), MasterControl (US), ERT (US), Forte Research Systems (US).
Research Methodology:
The study involved four major activities in estimating the current size for the risk-based monitoring (RBM) software market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
RBM Software Market Dynamics: Impact Analysis
1. Increased outsourcing of clinical trial processes to CROs
2. Cost and time efficiency of RBM solutions
3. Increasing government funding and grants to support clinical trials
4. Increased pharmaceutical R&D spending
5. Initiatives to boost digital health to propel market growth
The risk-based monitoring (RBM) software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a CAGR of 13.3%
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102112429
Software Component:
The software segment is expected to command the largest share of the RBM software market. The large share of this segment can be attributed to can be attributed to the increasing R&D expenditure in the life science and clinical research industries, an increasing number of clinical trials, and rising customer base.
Web Based (On Demand) Delivery Mode:
The Web-based (On-demand) segment is expected to command the largest share of the RBM software market. The large share of this segment can be attributed to the advantages offered by web-based software, such as easy access, improved productivity, time efficiency, and cost-efficiency.
The pharmaceutical and biopharmaceutical companies segment is expected to command the largest share of the RBM software market.
Key Questions Addressed in The Report:
1. Who are the top 10 players operating in the global RBM Software Market?
2. What are the drivers, restraints, opportunities, and challenges in the RBM Software Industry?
3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of RBM Software Industry in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?
Regional Growth Analysis:
North American market is expected to account for the largest share of the global RBM software market. The Asia Pacific market is expected to grow at the highest CAGR in the forecast period.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=102112429
Key Players:
Oracle (US), Medidata Solutions (US), and Parexel (US). Other prominent players in the market are Bioclinica (US), Bio-Optronics (US), IBM Corporation (US), DATATRAK (US), Veeva Systems (US), DSG (US), MasterControl (US), ERT (US), Forte Research Systems (US).
Research Methodology:
The study involved four major activities in estimating the current size for the risk-based monitoring (RBM) software market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Comments
Post a Comment